“We are confident in our 2024-2026 CAGR target of plus 6% to plus 8% organic topline growth, plus 8% to plus 10% organic operating income growth and plus 9% to plus 11% currency-neutral adjusted EPS growth.”

In context

“enting at the CECP CEO Investor Forum in New York on November 14th, and the event is open to all those who would like to attend. To conclude today's presentation, we continue to deliver sustainable growth through our transformation. The powerful trajectory of our smoke-free business give us confidence in strong full-year results, built on volume growth, positive mix, pricing and cost management. Considering the headwinds faced, notably in the first part of the year. We believe this speaks strongly to the fundamentals of our growth model. Notably, the outstanding performance of IQOS and ZYN continues, further enhancing our position as the global smoke-free champion. We have exciting plans to accelerate our smoke-free future in both the US. The largest smoke-free market and internationally. We are confident in our 2024-2026 CAGR target of plus 6% to plus 8% organic topline growth, plus 8% to plus 10% organic operating income growth and plus 9% to plus 11% currency-neutral adjusted EPS growth. We also as a clear guiding objective with our new ambition to be substantially smoke-free by net revenue in 2030 as another key milestone on our journey toward the smoke-free future. And finally with our latest dividend raise in September, we have delivered 16 years of continuous dividend increase since our 2008 spin, despite the ups and downs of economic and currency cycle. This translate to cumulative 183% increase and CAGR of 77.2% since 2008 with an annualized dividend of $5.20. As these demonstrate our commitment to shareholder return through a progressive dividend remain steadfast. Thank you very much. And we are now extremely happy to answer your questions. Operator: Thank you. We will now conduct the question-and-answer portion of the conference. [Operator Instructions] Our first”